< Back to previous page

Publication

Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin (vol 22, 126, 2021)

Journal Contribution - Journal Article

Journal: Trials

ISSN: 1745-6215

Issue: 1

Volume: 22

Pages: 0 - 0

Publication year:2021

WoS Id: 000626577200002
PubMed Id: 33673831
DOI: https://doi.org/10.1186/s13063-021-05153-4
Institutional Repository URL: https://lirias.kuleuven.be/3411135

See also: Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-ofconcept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial